WebApr 13, 2024 · Electronic medical records of 134 215 participants who received a Pfizer-BioNTech bivalent mRNA vaccine booster dose were compared with 435 304 … Web5 mcg rS and 50 mcg Matrix–M adjuvant. 3–8-week (21–56-day) interval. -. mRNA vaccine (bivalent) 2–month (60-day) interval‡. *Children and adults aged 6 years or older can receive a Pfizer-BioNTech or a Moderna bivalent booster, regardless of what they received in the primary series.
Pfizer-BioNTech COVID-19 Vaccine
WebAug 18, 2024 · The Pfizer BioNTech vaccine against COVID-19 has very high efficacy against severe disease and moderate efficacy against symptomatic SARS-CoV-2 … WebMar 1, 2024 · First booster dose (for vaccines supplied in vials with gray, purple, or orange caps): You may be given a first booster dose of Pfizer-BioNTech COVID-19 vaccine at least 5 months after your primary series with this vaccine. It is usually given to patients 5 years of age and older. A first booster dose of this vaccine may also be given to ... elsa with a baby
Moderna COVID-19 Vaccine, Bivalent: PI - Drugs.com
WebEach 0.2 mL dose of the Pfizer-BioNTech COVID-19 Vaccine supplied in multiple dose vials with orange caps and labels with orange borders contains 10 mcg of modRNA encoding the viral spike (S) glycoprotein of the SARS-CoV-2 Wuhan-Hu-1 strain. ... Individuals 5 through 11 years of age may receive a booster dose with the Pfizer … WebNov 4, 2024 · One-month after a 30-µg booster dose of the bivalent vaccine, Omicron BA.4/BA.5-neutralizing antibody titers increased 13.2-fold from pre-booster levels in adults older than 55 years of age and 9.5-fold in adults 18 to 55 years of age, compared to a 2.9-fold increase in adults older than 55 years or age who received the original booster vaccine WebA single booster dose (0.3 mL) of Pfizer-BioNTech COVID-19 Vaccine, Bivalent may be administered at least 2 months after completion of primary vaccination with any authorized or approved COVID-19 vaccine or after receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine. elsa worth it